You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recombinant human Surfactant Protein-D (rhSP-D)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lung Disease of Prematurity, Respiratory Distress Syndrome in Premature Infant, Bronchopulmonary Dysplasia Trial

Not yet recruiting
  • Chronic Lung Disease of Prematurity
  • +2 more
  • Recombinant fragment of human surfactant protein D (rfhSP-D)
  • (no location specified)
Jun 6, 2023

SARS CoV 2 Infection, Alveolar; Injury, Children Trial in Istanbul

Completed
  • SARS CoV 2 Infection
  • +3 more
    • Istanbul, Turkey
      Haseki Training and Research Hospital
    Nov 17, 2022

    Bronchopulmonary Dysplasia Trial in Spain, United States (AT-100, Air-sham)

    Recruiting
    • Bronchopulmonary Dysplasia
    • AT-100
    • Air-sham
    • Tucson, Arizona
    • +17 more
    Apr 28, 2022

    Pneumonia, Ventilator-Associated Trial in France (Interferon gamma, Placebo)

    Not yet recruiting
    • Pneumonia, Ventilator-Associated
    • Interferon gamma
    • Placebo
    • Lyon, France
    • +6 more
    May 2, 2023

    Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

    Recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • Recombinant Interleukin-7
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 26, 2023

    Recurrent Bladder Carcinoma, Bladder Cancer Stage 0, Bladder Cancer Stage I Trial in Los Angeles (Pharmacokinetic Study,

    Not yet recruiting
    • Recurrent Bladder Carcinoma
    • +2 more
    • Pharmacokinetic Study
    • Recombinant EphB4-HSA Fusion Protein
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Jan 31, 2023

    COVID-19 Trial in Natal, São Paulo, Rio De Janeiro (AstraZeneca/Fiocruz, Pfizer/Wyeth, Clover SCB-2019)

    Not yet recruiting
    • COVID-19
    • AstraZeneca/Fiocruz
    • +2 more
    • Natal, Rio Grande Do Norte, Brazil
    • +2 more
    Jul 21, 2022

    COVID-19 Pandemic Trial in Indonesia, Philippines, Russian Federation (Recombinant SARS-CoV-2 fusion protein vaccine (V-01),

    Active, not recruiting
    • COVID-19 Pandemic
    • Recombinant SARS-CoV-2 fusion protein vaccine (V-01)
    • Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
    • Padang, Indonesia
    • +24 more
    Aug 31, 2022

    Exercise Training, Dietary Supplements Trial in Thessaloniki (Fish nutrients, Whey protein, Maltodextrin)

    Active, not recruiting
    • Exercise Training
    • Dietary Supplements
    • Fish nutrients
    • +2 more
    • Thessaloniki, Greece
      Laboratory of Evaluation of Human Biological Performance
    May 31, 2022

    Covid-19 Infection: Case-Control Study

    Completed
    • Covid19
    • +2 more
      • Denizli, Outside Of The US, Turkey
        Aylin Koseler
      Nov 4, 2020

      Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Measles Trial in Shaoxing, Wuyi

      Active, not recruiting
      • Human Papilloma Virus Infection Type 16
      • +4 more
      • HPV+MMR（0d），HPV（6m）
      • +2 more
      • Shaoxing, Zhejiang, China
      • +1 more
      Mar 14, 2022

      Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Tumor Trial in Houston (Recombinant

      Active, not recruiting
      • Allogeneic Hematopoietic Stem Cell Transplant Recipient
      • Hematopoietic and Lymphoid Cell Neoplasm
      • Recombinant Human Papillomavirus Nonavalent Vaccine
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 29, 2022

      COVID-19 Pandemic Trial in Shaoguan (Recombinant SARS-CoV-2 Beta Variant Fusion Protein Vaccine/Recombinant SARS-CoV-2 Delta

      Active, not recruiting
      • COVID-19 Pandemic
      • Recombinant SARS-CoV-2 Beta Variant Fusion Protein Vaccine/Recombinant SARS-CoV-2 Delta Variant Fusion Protein Vaccine
      • Shaoguan, Guangdong, China
        Shaoguan Hospital of Chinese Medicine
      Mar 1, 2022

      COVID-19 Trial in Worldwide (SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1, SARS-CoV-2 recombinant protein

      Active, not recruiting
      • COVID-19
      • SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1
      • +10 more
      • Birmingham, Alabama
      • +71 more
      Jul 11, 2022

      Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blasts 5 Percent or More of Bone Marrow Nucleated Cells,

      Terminated
      • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
      • +10 more
      • Los Angeles, California
        USC / Norris Comprehensive Cancer Center
      Nov 17, 2021

      SARS CoV 2 Infection Trial in Spain, Turkey (PHH1-V)

      Recruiting
      • SARS CoV 2 Infection
      • PHH1-V
      • Badalona, Barcelona, Spain
      • +5 more
      Jun 21, 2022

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

      Recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +7 more
      • Blinatumomab
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 31, 2022

      Solid Tumor Trial in Los Angeles (laboratory biomarker analysis, pharmacological study, recombinant albumin fusion protein

      Active, not recruiting
      • Unspecified Adult Solid Tumor, Protocol Specific
      • laboratory biomarker analysis
      • +2 more
      • Los Angeles, California
        USC Norris Comprehensive Cancer Center
      Apr 1, 2021

      Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Houston (biological,

      Completed
      • Metastatic Melanoma
      • +3 more
      • Aldesleukin
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 27, 2022

      Healthy Volunteers Trial in Neuss (Biocon's Human Insulin R U-500, Humulin® R U-500 (US Reference Product))

      Recruiting
      • Healthy Volunteers
      • Biocon's Human Insulin R U-500
      • Humulin® R U-500 (US Reference Product)
      • Neuss, Germany
        Profil Institut für Stoffwechselforschung GmbH 9
      Jun 9, 2022

      Metastatic Carcinoma in the Liver, Resectable Mass, Stage IV Colorectal Cancer AJCC v7 Trial in Houston (biological, other,

      Completed
      • Metastatic Carcinoma in the Liver
      • +4 more
      • Durvalumab
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 30, 2023

      Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston

      Active, not recruiting
      • Metastatic Melanoma
      • +2 more
      • Aldesleukin
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 18, 2022

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,

      Recruiting
      • Acute Lymphoblastic Leukemia
      • +3 more
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +8 more
      • Duarte, California
        City of Hope Medical Center
      Jan 12, 2023

      Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

      Recruiting
      • Borderline Resectable Pancreatic Adenocarcinoma
      • +5 more
      • Durvalumab
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 12, 2022

      Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston

      Recruiting
      • Recurrent Lung Non-Small Cell Carcinoma
      • +3 more
      • Durvalumab
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 10, 2022